Procter & Gamble Stock News

Procter & Gamble has promised a group of shareholders it will disclose more details about how it audits wood-pulp suppliers, the investors told Reuters, after shareholders pushed the maker of Charmin toilet paper for years to source forest products more sustainably.

The end of the year is a perfect time to reflect on your investment journey. Part of that reflection can involve identifying mistakes worth avoiding or portfolio moves to make before the end of the year.

Investing in dividend stocks allows you to earn dividend income, the best passive income stream. The power of compounding and dividend reinvestment is a wonderful component to the portfolio. All of the investing from last year and moves this year show that my aim to save 60% of my income, and making every dollar count has provided the dividend growth.

When investors look for reliable dividend-paying companies, they typically consider factors such as the track record for paying and raising the dividend over time, if the company is an industry leader, if it is a growing business that can support a higher dividend expense, and the dividend yield.

Procter & Gamble boasts a robust brand portfolio and consistent dividends but is currently overvalued, making it a hold rather than a buy. Despite strong fundamentals and a wide economic moat, the stock's high valuation limits its potential for market-beating returns. The company has underperformed the S&P 500 for years and not provided much shelter in bear markets, limiting its appeal for risk...

Procter & Gamble has overhauled its supply chain for the tiny, extra-thin strips of stainless steel in its Gillette razors to source from India, a move expected to help protect its margins from any tariffs U.S. President-Elect Donald Trump may impose.

Verizon is the only Dow Dog meeting the ideal of annual dividends from $1K invested exceeding its single share price. Five more Dow Dogs, including Cisco and Merck, are within 66% of meeting this ideal. Analysts forecast 11.36% to 31.73% net gains from top-ten Dow Dogs by December 2025, with Merck leading at 31.73%.

Buying stocks when they are trading near their all-time highs is never easy. Our instincts tell us that paying a high price for something is a bad deal.